Location History:
- Lyons, FR (2015)
- Belleville, FR (2022)
Company Filing History:
Years Active: 2015-2022
Title: Vincent Moules: Innovator in Antiviral Research
Introduction
Vincent Moules is a notable inventor based in Lyons, France. He has made significant contributions to the field of antiviral research, particularly in the development of compositions aimed at treating infections linked to coronaviruses. With a total of 2 patents, his work is recognized for its potential impact on public health.
Latest Patents
Moules' latest patents include innovative solutions for combating viral infections. One of his key inventions is a pharmaceutical composition designed for the prevention and treatment of MERS-CoV (Middle-East Respiratory Syndrome) infections. This composition comprises at least one compound chosen from apigenin and berberine, formulated in a suitable pharmaceutical vehicle. Another significant patent involves modified viral strains and methods for enhancing the production of vaccine seeds for the influenza virus. This patent focuses on a modified influenza A/PR/8/34 virus, which includes a modified PB1 gene, aimed at improving the production of HA (hemagglutinin) and NA (neuraminidase) vaccine glycoproteins.
Career Highlights
Throughout his career, Vincent Moules has been associated with prestigious institutions such as Université Claude Bernard Lyon 1 and the Centre National de la Recherche Scientifique. His work at these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Moules has collaborated with esteemed colleagues, including Manuel Rosa-Calatrava and Olivier Ferraris. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.
Conclusion
Vincent Moules stands out as an innovative inventor in the field of antiviral research. His contributions, particularly in the development of antiviral compositions and vaccine production methods, highlight his commitment to improving public health. His work continues to inspire future advancements in the fight against viral infections.